13D/13G Filings - Stoke Therapeutics Inc. (STOK)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-08
10:33 am
Purchase
2021-02-05 13G Stoke Therapeutics, Inc.
STOK
FMR LLC 3,600,975
9.937%
3,600,975increase
(New Position)
Filing
History
2020-11-27
4:58 pm
Purchase
2020-11-20 13D Stoke Therapeutics, Inc.
STOK
ATP Life Science Ventures L.P. 17,206,045
47.500%
419,332increase
(+2.50%)
Filing
History
Goto Prev, 0, 1, 2